Steroid therapy for problematic proliferating haemangioma

New Zealand Medical Journal

Volumn 124, Issue 1329, 2011, Pages 57-65

  Tan, Beryl H ^a   Leadbitter, Philip ^a   Aburn, Neil ^b   Tan, Swee T ^a,c  

^a HUTT HOSPITAL   (New Zealand)

^b WELLINGTON HOSPITAL   (New Zealand)

^c UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROCORTISONE; OMEPRAZOLE; PREDNISOLONE; PROPRANOLOL; RANITIDINE; TRIAMCINOLONE;

ABSENCE OF SIDE EFFECTS; ADRENAL CORTEX INSUFFICIENCY; ARTICLE; ASTIGMATISM; COLOBOMA; CONTROLLED STUDY; CUSHINGOID SYNDROME; CYTOREDUCTIVE SURGERY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MEGADOSE; DRUG SAFETY; FEMALE; GASTROESOPHAGEAL REFLUX; GROWTH RETARDATION; HEMANGIOMA; HUMAN; INCREASED APPETITE; INFANT; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; OTITIS MEDIA; SIDE EFFECT; STEROID THERAPY; SYSTEMIC THERAPY; VASCULAR DISEASE; VISUAL IMPAIRMENT; WEIGHT GAIN;

ADMINISTRATION, ORAL; FEMALE; HEMANGIOMA; HUMANS; INFANT; INFANT, NEWBORN; INJECTIONS, INTRALESIONAL; MALE; PREDNISOLONE; TREATMENT OUTCOME; TRIAMCINOLONE;

EID: 79951469930     PISSN: None     EISSN: 11758716     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Zarem HA, Edgerton MT. Induced resolution of cavernous hemangiomas following prednisolone therapy. Plastic Reconstr Surg. 1967;39:76-83.
2. Hasan Q, Tan S, Gush J, et al. Steroid therapy of a proliferating hemangioma: histochemical and molecular changes. Pediatrics. 2000;105:117-120.
3. Boon LM, MacDonald D, Mulliken JB. Complications of systemic corticosteroid therapy for problematic hemangioma. Plast Reconstr Surg. 1999;104:1616-1623. (Pubitemid 29510480)
4. Bennett M, Fleischer A, Chamlin SL, et al. Oral corticosteroid use is effective for cutaneous hemangiomas - An evidence-based evaluation. Arch Dermatol. 2001;137(9):1208-1213. (Pubitemid 32847844)
5. Sloan GM, Reinisch JF, Nichter LS, et al. Intralesional corticosteroid therapy for infantile hemangiomas. Plast Reconstr Surg. 1989;83:459-467.
6. Chen MT, Yeong EK, Horng SY. Intralesional corticosteroid therapy in proliferating head and neck hemangiomas: a review of 155 cases. J Pediatr Surg. 2000;35:420-423. (Pubitemid 30131602)
7. Chantharatanapiboon W. Intralesional corticosteroid therapy in hemangiomas: clinical outcome in 160 cases. J Med Assoc Thailand. 2008;91 Suppl 3:S90-6.
8. Shorr N, Seiff S. Central retinal artery occlusion associated with periocular corticosteroid injection for juvenile hemangioma. Ophthalmic Surg. 1986;17(4):229-231. (Pubitemid 16117093)
9. Sutula FC, Glover AT. Eyelid necrosis following intralesional corticosteroid injection for capillary hemangioma. Ophthalmic Surg. 1987;18:103.
10. Léauté-Labrèze C, Dumas de la Rogue E, Hubiche T, et al. Propanolol for severe hemangiomas of infancy. NEJM. 2008;358(24):2649-2651.
11. Manunza F, Syed S, Lguda B, et al. Propranolol for complicated infantile haemangiomas: a case series of 30 infants [Correspondence]. Bri J Dermatol. 2010;162:466-468.
12. Tan ST, Itinteang T, Leadbitter P. Low dose optimal propranolol for the treatment of infantile haemangioma. JPRAS. 2010; DOI: 10.1016/j.bjps.2010.06. 010.
13. Itinteang T, Tan ST, Brasch H, Day DJ. Primitive mesodermal cells with a neural crest stem cells phenotype predominate proliferating haemangioma. J Clin Pathol. 2010;DOI:10.1136/jcp.2010.079368.
14. Itinteang T, Tan ST, Brasch H, Day DJ. Haemogenic endothelium in infantile haemangioma. J Clin Pathol. 2010;63:982-986.
15. Itinteang T, Tan ST, Brasch H, Day DJ. Expression of components of the renin-angiotensin system in proliferating haemangioma may account for propranolol induced accelerated involution. JPRAS. 2010;DOI:10.1016/j.bjps.2010. 08.039.